Inactive Instrument

Avricore Health Inc Stock Toronto S.E.

Equities

APH

CA92143R2046

Pharmaceuticals

Sales 2021 123K 89.77K Sales 2022 1.77M 1.29M Capitalization 31.26M 22.85M
Net income 2021 -1M -731K Net income 2022 - 0 EV / Sales 2021 111 x
Net cash position 2021 1.97M 1.44M Net cash position 2022 591K 432K EV / Sales 2022 17.3 x
P/E ratio 2021
-8.67 x
P/E ratio 2022
-37.7 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 90.31%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer - 18-12-31
Director of Finance/CFO - 19-08-05
Chief Tech/Sci/R&D Officer - 20-12-07
Members of the board TitleAgeSince
Chairman 71 16-01-19
Director/Board Member 71 18-03-26
Director/Board Member - 23-06-20
More insiders
Avricore Health Inc. is a pharmacy service company that is focused on acquiring and developing early-stage technologies. The Company is engaged in the business of health data and point-of-care technologies (POCT). It provides digital solutions that support the role of pharmacists and provide infrastructure for making clinical services more accessible and more affordable in its communities. The Company's offering includes HealthTab. HealthTab is a cloud-based network technology that enables the real-time response system where consumers receive a finger-stick blood test at their local pharmacy via a Web-enabled blood chemistry analyzer. Its HealthTab platform can test up to 27 biomarkers on the spot for screening and managing chronic conditions, such as diabetes. It also provides bacterial and viral testing for Strep and COVID-19. The Company's wholly owned subsidiary is HealthTab Inc.
More about the company